Lynch Syndrome Integrative Epidemiology and Genetics

NCT06582914 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-01-15

No results posted yet for this study

Summary

The vision of the "Lynch syndrome INtegrative Epidemiology And GEnetics" (LINEAGE) Consortium is to collaboratively improve the lives and longevity of individuals and families with Lynch syndrome.

The mission of the LINEAGE Consortium is to collaboratively improve Lynch syndrome care through high-quality research. This consortium will provide intellectual and infrastructure support to facilitate development of research questions, collection of standardized data and biospecimens, support of grant applications, and generation of collaborative manuscripts.

Our aims are to:

I. Establish a prospective cohort of individuals with Lynch syndrome II. Collect standardized longitudinal clinical and biosample data to elucidate Lynch Syndrome epidemiology and gene-host interactions III. Promote intervention trials to improve cancer prevention and early detection in Lynch Syndrome

Conditions

Sponsors & Collaborators

  • University of Chicago

    collaborator OTHER
  • University of Kansas

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • City of Hope National Medical Center

    collaborator OTHER
  • Loma Linda University

    collaborator OTHER
  • MedStar Health

    collaborator OTHER
  • University of Arizona

    collaborator OTHER
  • University of Manitoba

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • University of North Carolina

    collaborator OTHER
  • University of Pittsburgh

    collaborator OTHER
  • University of Rochester

    collaborator OTHER
  • Dana-Farber Cancer Institute

    collaborator OTHER
  • University of Wisconsin, Madison

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • University of California, San Diego

    collaborator OTHER
  • Kaiser Permanente

    collaborator OTHER
  • Ohio State University

    collaborator OTHER
  • Virginia Mason Hospital/Medical Center

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • University of Miami

    collaborator OTHER
  • University of Colorado, Denver

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2054-12-31
Completion
2054-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06582914 on ClinicalTrials.gov